Nanjing Hicin Pharmaceutical Co., Ltd. (300584.SZ) SHZ

51.24

+0.22(+0.43%)

Updated at December 05 03:04PM

Currency In CNY

Valuation

Market Cap2.42B
Enterprise Value2.68B
P/E Ratio137.31
PEG Ratio1.37
Price/Sales Ratio10.05
Price/Book Ratio5.89
Enterprise/Revenue10.41
Enterprise/EBITDA120.74

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.07
Operating Margin0.07

Management Effectiveness

Return On Assets0.03
Return On Equity0.04

Income Statement

Revenue504.36M
Revenue/Share5.1
Gross Profit419.38M
EBITDA102.94M
Net Income40.22M
Diluted EPS0.34

Balance Sheet

Total Cash76.14M
Total Cash/Share0.63
Total Debt297.34M
Total Debt/Equity0.28
Current Ratio1.01
Book Value Per Share8.94

Price History

52-Week Change132.38
52-Week High81.88
52-Week Low15.54
Moving Average 50 Days57.52
Moving Average 200 Days40.97

Statistics

Average Volume9.69M
Shares Outstanding120M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.1
Trailing Annual Dividend Yield0.2
Payout Ratio0.4
Last Split Factor3:2
Last Split DateApril 20, 2018